Dipyrone potentiates morphine-induced antinociception in dipyrone-treated and morphine-tolerant rats

European Journal of Pharmacology

Volumn 502, Issue 1-2, 2004, Pages 67-73

  Hernández Delgadillo, Gloria P ^a   Cruz, Silvia L ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Antinociception; Cross tolerance; Metamizol; Opioid; Potentiation; Tolerance

Indexed keywords

DIPYRONE; MORPHINE SULFATE;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG CROSS TOLERANCE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; DIPYRONE; DRUG SYNERGISM; DRUG TOLERANCE; MALE; MORPHINE; PAIN MEASUREMENT; RATS; RATS, WISTAR;

EID: 4744351526     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.08.032     Document Type: Article

References (49)

1. P. Aguirre-Bañuelos, and V. Granados-Soto Evidence for a peripheral mechanism of action for the potentiation of the antinociceptive effect of morphine by dipyrone J. Pharmacol. Toxicol. 42 1999 79 85
2. H. Akman, F. Aksu, I. Gultekin, H. Ozbek, U. Oral, F. Doran, and F. Baysal A possible central antinociceptive effect of dipyrone in mice Pharmacology 53 1996 71 78
3. A. Beirith, A.R.S. Santos, A.L.S. Rodrigues, T.B. Creczynski-Pasa, and B. Calixto Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action Eur. J. Pharmacol. 345 1998 233 245
4. K.C. Bentley, and T.W. Head The additive analgesic efficacy of acetaminophen, 1000 mg, and codeine, 60 mg, in dental pain Clin. Pharmacol. Ther. 42 1987 634 640
5. H.N. Bhargava Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behavior Pharmacol. Rev. 46 1994 293 324
6. C. Campos, R. De Gregorio, R. García-Nieto, F. Gago, P. Ortiz, and S. Alemany Regulation of cyclooxygenase activity by metamizol Eur. J. Pharmacol. 378 1999 339 347
7. K.H. Carlsson, and I. Jurna The role of descending inhibition in the antinociceptive effects of the pyrazolone derivatives, metamizol (dipyrone) and aminophenazone ("Pyramidon") Naunyn-Schmiedeberg's Arch. Pharmacol. 335 1987 154 159
8. D. Christensen, G. Guilbaud, and V. Kayser Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine-NMDA receptor antagonist (+)-HA966 in neuropathic rats Anesthesiology 92 2000 786 794
9. M.J. Christie, C.W. Vaughan, and S.L. Ingram Opioids, NSAIDS and 5-lipoxygenase inhibitors act synergistically in brain via arachidonic acid metabolism Inflamm. Res. 48 1999 1 4
10. D.L. Cichewicz Synergistic interactions between cannabinoid and opioid analgesics Life Sci. 74 2004 1317 1324
11. M. Curatolo, and G. Sveticic Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination Best Pract. Res., Clin. Anaesthesiol. 16 4 2002 507 519
12. F.E. D'Amour, and D.L. Smith A method for determining loss of pain sensation J. Pharmacol. Exp. Ther. 72 1941 74 79
13. K. Elliot, A. Hynansky, and C.E. Inturrisi Dextromethorphan attenuates and reverses analgesic tolerance to morphine Pain 59 1994 361 368
14. M. Gibaldi Estimation of area under the curve M. Gibaldi Biopharmaceutics and Clinical Pharmacokinetics Fourth edition 1991 Lea & Febiger Pennsylvania, USA 377 378
15. M. Grotto, S. Dikstein, and F.G. Sulman Additive and augmentative synergism between analgesic drugs Arch. Int. Pharmacodyn. 155 1965 365 372
16. H.B. Gutstein, and H. Akil Opioid analgesics J.G. Hardman L.E. Limbird A. Goodman Gilman Goodman & Gilman's The Pharmacological Basis of Therapeutics Tenth edition 2001 McGraw Hill USA 569 619
17. G.P. Hernández-Delgadillo, R. Ventura, M.I. Diaz, A.M. Dominguez, and F.J. Lopez-Muñoz Metamizol potentiates morphine antinociception but not constipation after chronic treatment Eur. J. Pharmacol. 441 2002 177 183
18. G.P. Hernández-Delgadillo, F.J. Lopez-Muñoz, L.A. Salazar, and S.L. Cruz Morphine and dipyrone co-administration delays tolerance development and potentiates antinociception Eur. J. Pharmacol. 469 2003 71 79
19. S.L. Jones Dipyrone into the nucleus raphe magnus inhibits the rat nociceptive tail-flick reflex Eur. J. Pharmacol. 318 1996 37 40
20. Y.A. Kolesnikov, and G.W. Pasternak Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-d-aspartate antagonist J. Pharmacol. Exp. Ther. 290 1999 247 252
21. Y.A. Kolesnikov, C.G. Pick, G. Ciszewska, and G.W. Pasternak Blockade of tolerance to morphine but not to κ opioids by a nitric oxide synthase inhibitor Proc. Natl. Acad. Sci. 90 1993 5162 5166
22. Y.A. Kolesnikov, M.L. Maccechini, and G.W. Pasternak 1-aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance Life Sci. 55 1994 1393 1398
23. 2-inhibitors in nerve-injured rats Pain 82 1999 65 72
24. F.J. Lopez-Muñoz Surface of synergistic interaction between dipyrone and morphine in the PIFIR model Drug Dev. Res. 33 1994 26 32
25. R.D. MacPherson New directions in pain management Drugs Today 38 2002 135 145
26. A.B. Malmberg, and T.L. Yaksh Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction Anesthesiology 79 1993 270 281
27. T.J. Martin, and J.C. Eisenach Pharmacology of opioid and nonopioid analgesics in chronic pain states J. Pharmacol. Exp. Ther. 299 2001 811 817
28. T.J. Maves, P.S. Pechman, S.T. Meller, and G.F. Gebhart Ketorolac potentiates morphine antinociception during visceral nociception in the rat Anesthesiology 80 1994 1094 1101
29. S. Mercadante Problems of long-term spinal opioid treatment in advanced cancer patients Pain 79 1999 1 13
30. P.W. Nance, and J. Sawynok Substance P-induced long-term blockade of spinal adrenergic analgesia: reversal by morphine and naloxone J. Pharmacol. Exp. Ther. 240 1987 972 977
31. C.V. Patel, M.G. Kappikar, M.S. Patel, G.B. Parulkar, and P.L.M. Pinto Management of pain after abdominal surgery: dipyrone compared with pethidine Br. J. Clin. Pharmacol. 10 1980 351S 354S
32. P. Picard, J.E. Bazin, N. Conio, F. Ruiz, and P. Schoeffler Ketorolac potentiates morphine in postoperative patient-controlled analgesia Pain 73 1997 401 406
33. M.E. Planas, C. Gay-Escoda, J.V. Bagan, J. Santamaria, M. Peñarrocha, M. Donado, J.L. Puerta, I. Garcia-Magaz, J. Ruiz, and P. Ortiz Oral metamizol (1 g and 2 g) versus ibuprofen and placebo in the treatment of lower third molar surgery pain: randomized double-blind multi-centre study Eur. J. Clin. Pharmacol. 53 1998 405 409
34. P. Popik, E. Kozela, and W. Danysz Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice Naunyn-Schmiedeberg's Arch. Pharmacol. 361 2000 425 432
35. K.J. Powell, A. Hosokawa, A. Bell, M. Sutak, B. Milne, R. Quirion, and K. Jhamandas Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance Br. J. Pharmacol. 127 1999 631 644
36. C. Ripamonti, and E.D. Dickerson Strategies for the treatment of cancer pain in the new millennium Drugs 61 2001 955 977
37. L.J. Roberts, and J.D. Morrow Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout J.G. Hardman L.E. Limbird A. Goodman Gilman Goodman & Gilman's The Pharmacological Basis of Therapeutics Tenth edition 2001 McGraw Hill USA 687 731
38. M. Rodriguez, C. Barutell, M. Rull, R. Galvez, J. Pallares, F. Vidal, L. Aliaga, J. Moreno, J. Puerta, and P. Ortiz Efficacy and tolerance of oral dipyrone versus oral morphine for cancer pain Eur. J. Cancer 30A 1994 584 587
39. S. Sanchez, C. Alarcon de la Lastra, P. Ortiz, V. Motilva, and M.J. Martin Gastrintestinal tolerability of metamizol, acetaminophen, and diclofenac in subchronic treatment in rats Dig. Dis. Sci. 47 2002 2791 2798
40. A.J.M. Seegers, L.P. Jager, P. Zandberg, and J. van Noordwijk The anti-inflamatory, analgesic, and antipyretic activities of non-narcotic analgesic drug mixtures in rats Arch. Int. Pharmacodyn. 251 1981 237 254
41. A. Sunshine, and N.Z. Olson Nonnarcotic analgesics P.D. Wall R. Melzack Textbook of Pain Third edition 1994 Churchill Livingstone USA 923 942
42. J. Taylor, B. Mellstrom, I. Fernaud, and J.R. Naranjo Metamizol potentiates morphine effects on visceral pain and evoked c-Fos immunoreactivity in spinal cord Eur. J. Pharmacol. 351 1998 39 47
43. P.J. Tiseo, and C.E. Inturrisi Attenuation and reversal of morphine tolerance by the competitive N-methyl-d-aspartate receptor antagonist, LY274614 J. Pharmacol. Exp. Ther. 264 1993 1090 1096
44. P.J. Tiseo, J. Cheng, G.W. Pasternak, and C.E. Inturrisi Modulation of morphine tolerance by the competitive N-methyl-d-aspartate receptor antagonist LY274614: assessment of opioid receptor changes J. Pharmacol. Exp. Ther. 268 1994 195 201
45. V. Tortorici, and H. Vanegas Opioid tolerance induced by metamizol (dipyrone) microinjections into the periaqueductal grey of rats Eur. J. Neurosci. 12 2000 4074 4080
46. V. Tortorici, E. Vasquez, and H. Vanegas Naloxone partial reversal of the antinociception produced by dipyrone microinjected into the periaqueductal gray of rats. Possible involvement of medullary off- and on-cells Brain Res. 725 1996 106 110
47. R.G. Twycross Opioids P.D. Wall R. Melzack Textbook of Pain Fourth edition 1997 Churchill Livingstone USA 1187 1214
48. K.U. Weithmann, and H.G. Alpermann Biochemical and pharmacological effects of dipyrone and its metabolites in model systems related to arachidonic acid cascade Arzneim.-Forsch. 35 1985 947 952
49. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110